← Leaderboards
Ruben Claudio Aguilar
Purdue University
$2,924,185
Attributed
$2,924,185
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $348.6K · FY2012–25$500K$375K$250K$125K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,924,185 · 5
By mechanism
R01$2,362,439 · 2
R21$541,746 · 2
R13$20,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectDesignPharmaceutical PreparationsBirthGenesCessation Of LifeChildPhenotypeSymptomsUptakeKidneyCataractOculocerebrorenal SyndromeProteinsInvestigationMutationLipidsAnimal ModelKidney FailureLeadMental RetardationIn VitroGenetic DiseasesMutant
Grant awards (12)
Restoring Ocrl1 function in Lowe Syndrome and Dent-2 disease$342,239
R01 · FY2025 · DK · contact PI
Restoring Ocrl1 function in Lowe Syndrome and Dent-2 disease$328,550
R01 · FY2024 · DK · contact PI
International Lowe Syndrome Symposium$20,000
R13 · FY2024 · DK · contact PI
Restoring Ocrl1 function in Lowe Syndrome and Dent-2 disease$336,456
R01 · FY2023 · DK · contact PI
Restoring Ocrl1 function in Lowe Syndrome and Dent-2 disease$344,921
R01 · FY2022 · DK · contact PI
Restoring Ocrl1 function in Lowe Syndrome and Dent-2 disease$345,419
R01 · FY2021 · DK · contact PI
Lowe Syndrome: Therapeutic Strategy by Drug Repositioning$219,121
R01 · FY2019 · DK · contact PI
Lowe Syndrome: Therapeutic Strategy by Drug Repositioning$219,110
R01 · FY2018 · DK · contact PI
Lowe Syndrome: Therapeutic Strategy by Drug Repositioning$226,623
R01 · FY2017 · DK · contact PI
Targeting of Bladder Tumor Cells by Nanocarriers Bearing bacillus Calmette-Guerin$189,817
R21 · FY2014 · CA · contact PI
Targeting of Bladder Tumor Cells by Nanocarriers Bearing bacillus Calmette-Guerin$162,443
R21 · FY2013 · CA · contact PI
Characterization of the Multiple Myeloma Cancer Stem Cell and its Niche$189,486
R21 · FY2012 · CA · contact PI